Related Experiment Videos

Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a

Hans Stenlund1, Göran Lönnberg, Paul Jenkins

  • 1Department of Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University, Umeå, Sweden. hans.stenlund@epiph.umu.se

Insights

The Systematic Coronary Risk Evaluation (SCORE) equation significantly overestimated cardiovascular disease deaths in a northern Swedish population. This study highlights potential overestimation issues with the SCORE guidelines in specific European regions.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease risk prediction models are crucial but vary in accuracy.
  • Concerns exist regarding the Systematic Coronary Risk Evaluation (SCORE) equation's potential to overestimate risk in certain European populations.
  • Accurate risk assessment is vital for effective cardiovascular disease prevention strategies.

Purpose of the Study:

  • To evaluate the accuracy of the SCORE guidelines in predicting fatal cardiovascular events.
  • To assess potential overestimation of cardiovascular risk by the SCORE equation in a northern Swedish cohort.
  • To provide data on the performance of cardiovascular risk prediction tools in diverse European populations.

Main Methods:

  • Applied the SCORE guidelines to a large cohort (22,350 participants) from the Västerbotten Intervention Program in northern Sweden.
  • Included male and female participants screened at ages 40, 50, or 60 years between 1990-1994.
  • Followed participants for at least 10 years or until death to record fatal cardiovascular events.

Main Results:

  • A total of 229 fatal cardiovascular events occurred in the cohort (169 men, 60 women).
  • The SCORE risk chart predicted 359 events (266 men, 93 women).
  • Observed events were substantially lower than predicted events, indicating overestimation.

Conclusions:

  • The application of SCORE guidelines led to a significant overestimation of expected cardiovascular disease deaths in this northern Swedish population.
  • Findings suggest that the SCORE equation may not accurately reflect cardiovascular risk in this specific European demographic.
  • Further validation and potential recalibration of cardiovascular risk prediction tools are warranted for different populations.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...